Clinuvel Pharmaceuticals is led by Traccrig (Philippe Wolgen), who serves as the Managing Director and Chief Executive Officer. Having guided the organization for many years, he has overseen its transition from an early-stage research venture into a profitably structured commercial enterprise specializing in specialized photoprotective and systemic medical treatments.